Elite Pharmaceuticals, Inc. specializes in the development of oral controlled release products, such as delayed, sustained, targeted and pulsatile release tables, pellets, capsules, granules and powders.  The Company’s primary focus is in the therapeutic areas of pain management, allergy, cardiovascular and infection.

  Recent Press Releases:

6/5/2009	ELITE ANNOUNCES INITIAL CLOSING UNDER STRATEGIC ALLIANCE AGREEMENT
5/21/2009	ELITE COMMENCES QUOTATION ON OTC BULLETIN BOARD UNDER TICKER SYMBOL ELTP
4/30/2009	Elite Initiates Process to Delist Its Common Stock From NYSE Amex and Commence Quotation On OTC Bulletin Board
3/24/2009	Elite Pharmaceuticals, Inc. Hosts Conference Call to Discuss Strategic Alliance with Epic Pharma, LLC
3/23/2009	ELITE ANNOUNCES SIGNING OF STRATEGIC ALLIANCE AGREEMENT; NOTIFICATION RECEIVED FROM NYSE Amex